Matrix metalloproteinase-7 is increased in lung bases but not apices in idiopathic pulmonary fibrosis.
Journal
ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
22
04
2022
accepted:
02
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Idiopathic pulmonary fibrosis (IPF) is a progressively fibrotic lung condition with poor prognosis. Matrix metalloproteinase-7 (MMP7) is a protein secreted by epithelial cells in IPF lungs. It is not known if MMP7 expression correlates with fibrotic changes in lung tissue. Tissue samples from lung apices and bases were obtained from 20 IPF patients and 14 non-diseased control (NDC) donors. In formalin-fixed paraffin-embedded sections, histological assessment of fibrosis was performed; overall MMP7 positivity was assessed by immunohistochemistry and MMP7 Lung tissue from IPF bases was more fibrotic than in apices. MMP7 protein is elevated in IPF lung base tissue. In IPF whole lung lysates, MMP7 protein levels are increased compared to NDC donors and was increased in IPF lung bases compared to apices. MMP7 protein levels correlated with MMP7 gene expression levels in lung tissue. MMP7 transcript levels were increased in IPF base compared to NDC base lung tissue and increased in IPF base tissue compared to IPF apex tissue. Our cross-sectional study suggests that lung epithelial MMP7 expression increases as the tissue becomes more fibrotic and identifies a potentially nonepithelial or immune-cell source. Mechanisms of disease progression in IPF are still unclear, and our study suggests aberrant MMP7 production may be a histological starting point of lung tissue fibrosis.
Identifiants
pubmed: 36299365
doi: 10.1183/23120541.00191-2022
pii: 00191-2022
pmc: PMC9589331
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright ©The authors 2022.
Déclaration de conflit d'intérêts
Conflict of interest: M. Wong has received support for the present manuscript from CSL; the following disclosures have been made outside the submitted work: employee of CSL Innovations Pty Ltd, who provided support for attending meetings/travel; shareholder of CSL stocks. M. Alhamdoosh has received support for the present manuscript from CSL; the following disclosures have been made outside the submitted work: employee of CSL Limited and shareholder of CSL Limited. L. McMillan has received support for the present manuscript from CSL; the following relationships have been disclosed outside the submitted work: employee of CSL Innovations. C. Gamell-Fulla has received support for the present manuscript from CSL. M. Ng reports the following relationships have been disclosed outside the submitted work: employment contract with CSL and stocks owned in CSL. G. Westall has received support for the present manuscript from CSL; the following relationships have been disclosed outside the submitted work: participation in an Advisory Board Meeting for CSL. The remaining authors have nothing to disclose.
Références
Int J Mol Sci. 2018 Aug 23;19(9):
pubmed: 30142879
J Clin Med. 2021 Jul 18;10(14):
pubmed: 34300333
Exp Lung Res. 2014 Apr;40(3):126-36
pubmed: 24624896
J Biol Chem. 2009 Oct 9;284(41):27924-27932
pubmed: 19654318
Biomed Res Int. 2013;2013:654354
pubmed: 23841084
Am J Physiol Lung Cell Mol Physiol. 2016 May 1;310(9):L824-36
pubmed: 26944089
Lipids Health Dis. 2020 Jun 3;19(1):122
pubmed: 32493486
Am J Respir Cell Mol Biol. 2013 Apr;48(4):422-30
pubmed: 23258227
Respir Res. 2001;2(1):10-9
pubmed: 11686860
Sci Rep. 2017 Jan 31;7:41770
pubmed: 28139758
Expert Rev Respir Med. 2019 Jul;13(7):615-619
pubmed: 31117843
J Clin Invest. 2014 Apr;124(4):1622-35
pubmed: 24590289
Exp Biol Med (Maywood). 2006 Jan;231(1):20-7
pubmed: 16380641
Chest. 2013 May;143(5):1422-1429
pubmed: 23715088
Int J Mol Sci. 2021 Dec 14;22(24):
pubmed: 34948231
PLoS One. 2008 May 14;3(5):e2142
pubmed: 18478089
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6292-7
pubmed: 11983918
JCI Insight. 2019 Nov 14;4(22):
pubmed: 31600171
Chest. 2020 Aug;158(2):646-659
pubmed: 32268131
Int J Oncol. 2006 Feb;28(2):369-74
pubmed: 16391791
Nat Rev Immunol. 2021 Jun;21(6):347-362
pubmed: 33442032
Prog Histochem Cytochem. 2004;39(1):1-83
pubmed: 15242101
Eur Respir J. 2021 Sep 29;59(4):
pubmed: 34588192
Am J Respir Cell Mol Biol. 2020 Dec;63(6):819-830
pubmed: 32926636
Biology (Basel). 2022 Jan 12;11(1):
pubmed: 35053115
Eur Respir Rev. 2019 Sep 4;28(153):
pubmed: 31484664
Am J Respir Crit Care Med. 2012 Jan 1;185(1):67-76
pubmed: 22016448
Lancet Respir Med. 2020 Sep;8(9):925-934
pubmed: 32890499
Physiol Rev. 2016 Oct;96(4):1567-91
pubmed: 27630174
Eur Respir Rev. 2012 Dec 1;21(126):355-61
pubmed: 23204124
J Clin Med. 2019 Sep 11;8(9):
pubmed: 31514468
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Proc Am Thorac Soc. 2006 Jun;3(4):364-72
pubmed: 16738202
Histochem Cell Biol. 2008 Jun;129(6):705-33
pubmed: 18461349
Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L715-31
pubmed: 20363851
ERJ Open Res. 2017 Mar 22;3(1):
pubmed: 28435843
Lab Invest. 2017 Mar;97(3):232-242
pubmed: 27941755
JCI Insight. 2016 Dec 8;1(20):e90558
pubmed: 27942595
Mol Cell Biochem. 2003 Nov;253(1-2):269-85
pubmed: 14619979
Respirology. 2017 Apr;22(3):486-493
pubmed: 27761978